What is Neurobrands?
Neurobrands operates at the intersection of wellness and consumer packaged goods, specializing in functional beverages engineered to optimize mental and physical performance. By leveraging scientifically-backed ingredients, the company has developed a diverse portfolio including neuroSONIC for cognitive energy, neuroBLISS for stress management, and neuroSLEEP for sleep hygiene. The brand effectively targets health-conscious demographics, utilizing a multi-format distribution strategy that encompasses cans, bottles, and powder sticks. This product diversification allows Neurobrands to maintain a strong foothold in the retail landscape, appealing to both adults and younger consumers seeking targeted physiological benefits through daily consumption habits.
How much funding has Neurobrands raised?
Neurobrands has raised a total of $1.2M across 2 funding rounds:
Debt
$350K
Debt
$865K
Debt (2020): $350K with participation from PPP
Debt (2021): $865K led by PPP
Key Investors in Neurobrands
PPP
Public-Private Partnership
What's next for Neurobrands?
With the recent infusion of capital, Neurobrands is positioned to accelerate its enterprise-level scaling initiatives. The strategic focus will likely shift toward optimizing supply chain efficiencies and expanding retail distribution channels to capture a larger share of the functional beverage market. As the company matures, the integration of advanced R&D will be critical to maintaining its competitive edge against emerging wellness brands. Future growth will depend on the firm's ability to scale its manufacturing capabilities while maintaining the high-quality standards that define its product efficacy. Investors will be monitoring the company's ability to leverage this debt-based financing to drive sustainable revenue growth and solidify its brand equity in a crowded, high-growth industry.
See full Neurobrands company page
